Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)
Taiwan
· Delayed Price · Currency is TWD 11.45
0.00 (0.00%)
Apr 29, 2026, 1:41 PM CST
TPEX:4186 Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 1,031 | 1,418 | 1,485 | 1,593 | 1,674 | 2,282 | Upgrade
|
| Market Cap Growth | -29.10% | -4.54% | -6.78% | -4.84% | -26.63% | 53.00% | Upgrade
|
| Enterprise Value | 1,172 | 1,566 | 1,648 | 1,716 | 1,780 | 2,522 | Upgrade
|
| Last Close Price | 11.45 | 15.75 | 16.50 | 17.70 | 18.60 | 25.35 | Upgrade
|
| PE Ratio | 44.76 | 61.97 | - | 502.52 | - | - | Upgrade
|
| PS Ratio | 2.77 | 4.00 | 4.70 | 5.01 | 6.88 | 9.69 | Upgrade
|
| PB Ratio | 4.08 | 5.53 | 6.35 | 6.51 | 6.93 | 6.36 | Upgrade
|
| P/TBV Ratio | 4.08 | 5.53 | 6.35 | 6.61 | 7.24 | 6.81 | Upgrade
|
| P/FCF Ratio | 201.98 | 324.59 | 2226.39 | - | - | - | Upgrade
|
| P/OCF Ratio | 82.68 | 170.23 | 117.78 | - | - | - | Upgrade
|
| EV/Sales Ratio | 3.15 | 4.42 | 5.22 | 5.39 | 7.31 | 10.70 | Upgrade
|
| EV/EBITDA Ratio | 18.29 | 27.80 | 71.28 | 55.41 | - | - | Upgrade
|
| EV/EBIT Ratio | 26.93 | 37.95 | 677.30 | 225.46 | - | - | Upgrade
|
| EV/FCF Ratio | 229.72 | 358.55 | 2470.58 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 1.01 | 0.90 | 1.31 | 1.14 | 1.03 | 0.74 | Upgrade
|
| Debt / EBITDA Ratio | 3.98 | 3.71 | 10.84 | 7.81 | - | - | Upgrade
|
| Debt / FCF Ratio | 50.01 | 52.59 | 460.63 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.56 | 0.48 | 0.54 | 0.50 | 0.37 | 0.08 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.42 | 2.19 | 5.41 | 3.91 | -1.15 | -0.50 | Upgrade
|
| Net Debt / FCF Ratio | 27.74 | 28.24 | 187.56 | -4.35 | -1.41 | -0.28 | Upgrade
|
| Asset Turnover | 0.53 | 0.50 | 0.43 | 0.45 | 0.32 | 0.32 | Upgrade
|
| Inventory Turnover | 5.70 | 5.47 | 5.27 | 5.29 | 4.83 | 4.21 | Upgrade
|
| Quick Ratio | 0.78 | 0.85 | 0.74 | 0.91 | 0.93 | 1.35 | Upgrade
|
| Current Ratio | 0.90 | 0.96 | 0.82 | 1.07 | 1.09 | 1.61 | Upgrade
|
| Return on Equity (ROE) | 9.72% | 9.33% | -4.46% | 1.30% | -39.48% | -31.18% | Upgrade
|
| Return on Assets (ROA) | 3.91% | 3.62% | 0.21% | 0.67% | -8.36% | -7.14% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.04% | 11.17% | 0.67% | 1.88% | -28.58% | -22.45% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.20% | 9.40% | 0.60% | 1.60% | -21.90% | -13.90% | Upgrade
|
| Earnings Yield | 2.27% | 1.61% | -0.72% | 0.20% | -7.08% | -3.79% | Upgrade
|
| FCF Yield | 0.50% | 0.31% | 0.04% | -1.75% | -3.78% | -4.58% | Upgrade
|
| Buyback Yield / Dilution | - | - | - | - | -11.05% | -6.92% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.